Table 2 Treatment characteristics
Characteristics (N=62) | n (%) | |
|---|---|---|
Chemotherapy before hRT | ||
No | 29 (47) | |
Yes | 33 (53) | |
Time last ChT to hRT (months) | ||
Median (range) | 3 (0.2-43) | |
Chemotherapy during hRT | ||
No | 60 (97) | |
Yes | 2 (3) | |
Other RT prior hRT* | ||
No | 54 (87) | |
Yes | 8 (13) | |
Time last RT to hRT (months) | ||
Median (range) | 32 (2–128) | |
Other hemostatic measure | ||
No | 49 (79) | |
Yes | 13 (21) | |
Total hRT dose (Gy) | ||
Median (range) | 20 (5–45) | |
Region treated by hRT | ||
Uterovaginal | 19 (31) | |
Bladder | 17 (27) | |
Lung | 10 (16) | |
Upper GI | 10 (16) | |
Other# | 6 (10) | |
Treatment time hRT (days) | ||
Median (range) | 8 (1–25) |